 | • レポートコード：MRC2-11QY11881 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は勃起不全（ED）のグローバル市場について調査・分析したレポートです。種類別（ED薬品、ED装置）市場規模、用途別（先天性患者、病的患者）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別勃起不全（ED）の競争状況、市場シェア ・世界の勃起不全（ED）市場：種類別市場規模 2015年-2020年（ED薬品、ED装置） ・世界の勃起不全（ED）市場：種類別市場規模予測 2021年-2026年（ED薬品、ED装置） ・世界の勃起不全（ED）市場：用途別市場規模 2015年-2020年（先天性患者、病的患者） ・世界の勃起不全（ED）市場：用途別市場規模予測 2021年-2026年（先天性患者、病的患者） ・北米の勃起不全（ED）市場分析：米国、カナダ ・ヨーロッパの勃起不全（ED）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの勃起不全（ED）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の勃起不全（ED）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの勃起不全（ED）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eli Lilly、Pfizer、Bayer、Boston Scientific、Coloplast、Apricus Biosciences、Cristalia Produtos Quimicos Farmaceuticos、Dong-A Socio、Endo Pharmaceuticals、Futura Medical、Meda Pharmaceuticals、Promedon、SK Chemical、Teva Pharmaceuticals、Vivus、Zephyr Surgical Implants (ZSI) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.
The ED drugs segment led the market and accounted for almost 80% of the market share in terms of revenue.
Market Analysis and Insights: Global Erectile Dysfunction Market
The global Erectile Dysfunction market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Erectile Dysfunction Scope and Market Size
Erectile Dysfunction market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)
Market segment by Type, the product can be split into
ED Drugs
ED Devices
Market segment by Application, split into
Congenital Patients
Pathological Patients
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Erectile Dysfunction Revenue
1.4 Market by Type
1.4.1 Global Erectile Dysfunction Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 ED Drugs
1.4.3 ED Devices
1.5 Market by Application
1.5.1 Global Erectile Dysfunction Market Share by Application: 2020 VS 2026
1.5.2 Congenital Patients
1.5.3 Pathological Patients
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Erectile Dysfunction Market Perspective (2015-2026)
2.2 Global Erectile Dysfunction Growth Trends by Regions
2.2.1 Erectile Dysfunction Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Erectile Dysfunction Historic Market Share by Regions (2015-2020)
2.2.3 Erectile Dysfunction Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Erectile Dysfunction Market Growth Strategy
2.3.6 Primary Interviews with Key Erectile Dysfunction Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Erectile Dysfunction Players by Market Size
3.1.1 Global Top Erectile Dysfunction Players by Revenue (2015-2020)
3.1.2 Global Erectile Dysfunction Revenue Market Share by Players (2015-2020)
3.1.3 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Erectile Dysfunction Market Concentration Ratio
3.2.1 Global Erectile Dysfunction Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Revenue in 2019
3.3 Erectile Dysfunction Key Players Head office and Area Served
3.4 Key Players Erectile Dysfunction Product Solution and Service
3.5 Date of Enter into Erectile Dysfunction Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Erectile Dysfunction Historic Market Size by Type (2015-2020)
4.2 Global Erectile Dysfunction Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Erectile Dysfunction Market Size by Application (2015-2020)
5.2 Global Erectile Dysfunction Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Erectile Dysfunction Market Size (2015-2020)
6.2 Erectile Dysfunction Key Players in North America (2019-2020)
6.3 North America Erectile Dysfunction Market Size by Type (2015-2020)
6.4 North America Erectile Dysfunction Market Size by Application (2015-2020)
7 Europe
7.1 Europe Erectile Dysfunction Market Size (2015-2020)
7.2 Erectile Dysfunction Key Players in Europe (2019-2020)
7.3 Europe Erectile Dysfunction Market Size by Type (2015-2020)
7.4 Europe Erectile Dysfunction Market Size by Application (2015-2020)
8 China
8.1 China Erectile Dysfunction Market Size (2015-2020)
8.2 Erectile Dysfunction Key Players in China (2019-2020)
8.3 China Erectile Dysfunction Market Size by Type (2015-2020)
8.4 China Erectile Dysfunction Market Size by Application (2015-2020)
9 Japan
9.1 Japan Erectile Dysfunction Market Size (2015-2020)
9.2 Erectile Dysfunction Key Players in Japan (2019-2020)
9.3 Japan Erectile Dysfunction Market Size by Type (2015-2020)
9.4 Japan Erectile Dysfunction Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Erectile Dysfunction Market Size (2015-2020)
10.2 Erectile Dysfunction Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Erectile Dysfunction Market Size by Type (2015-2020)
10.4 Southeast Asia Erectile Dysfunction Market Size by Application (2015-2020)
11 India
11.1 India Erectile Dysfunction Market Size (2015-2020)
11.2 Erectile Dysfunction Key Players in India (2019-2020)
11.3 India Erectile Dysfunction Market Size by Type (2015-2020)
11.4 India Erectile Dysfunction Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Erectile Dysfunction Market Size (2015-2020)
12.2 Erectile Dysfunction Key Players in Central & South America (2019-2020)
12.3 Central & South America Erectile Dysfunction Market Size by Type (2015-2020)
12.4 Central & South America Erectile Dysfunction Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Eli Lilly
13.1.1 Eli Lilly Company Details
13.1.2 Eli Lilly Business Overview
13.1.3 Eli Lilly Erectile Dysfunction Introduction
13.1.4 Eli Lilly Revenue in Erectile Dysfunction Business (2015-2020))
13.1.5 Eli Lilly Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Erectile Dysfunction Introduction
13.2.4 Pfizer Revenue in Erectile Dysfunction Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Erectile Dysfunction Introduction
13.3.4 Bayer Revenue in Erectile Dysfunction Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Boston Scientific
13.4.1 Boston Scientific Company Details
13.4.2 Boston Scientific Business Overview
13.4.3 Boston Scientific Erectile Dysfunction Introduction
13.4.4 Boston Scientific Revenue in Erectile Dysfunction Business (2015-2020)
13.4.5 Boston Scientific Recent Development
13.5 Coloplast
13.5.1 Coloplast Company Details
13.5.2 Coloplast Business Overview
13.5.3 Coloplast Erectile Dysfunction Introduction
13.5.4 Coloplast Revenue in Erectile Dysfunction Business (2015-2020)
13.5.5 Coloplast Recent Development
13.6 Apricus Biosciences
13.6.1 Apricus Biosciences Company Details
13.6.2 Apricus Biosciences Business Overview
13.6.3 Apricus Biosciences Erectile Dysfunction Introduction
13.6.4 Apricus Biosciences Revenue in Erectile Dysfunction Business (2015-2020)
13.6.5 Apricus Biosciences Recent Development
13.7 Cristalia Produtos Quimicos Farmaceuticos
13.7.1 Cristalia Produtos Quimicos Farmaceuticos Company Details
13.7.2 Cristalia Produtos Quimicos Farmaceuticos Business Overview
13.7.3 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Introduction
13.7.4 Cristalia Produtos Quimicos Farmaceuticos Revenue in Erectile Dysfunction Business (2015-2020)
13.7.5 Cristalia Produtos Quimicos Farmaceuticos Recent Development
13.8 Dong-A Socio
13.8.1 Dong-A Socio Company Details
13.8.2 Dong-A Socio Business Overview
13.8.3 Dong-A Socio Erectile Dysfunction Introduction
13.8.4 Dong-A Socio Revenue in Erectile Dysfunction Business (2015-2020)
13.8.5 Dong-A Socio Recent Development
13.9 Endo Pharmaceuticals
13.9.1 Endo Pharmaceuticals Company Details
13.9.2 Endo Pharmaceuticals Business Overview
13.9.3 Endo Pharmaceuticals Erectile Dysfunction Introduction
13.9.4 Endo Pharmaceuticals Revenue in Erectile Dysfunction Business (2015-2020)
13.9.5 Endo Pharmaceuticals Recent Development
13.10 Futura Medical
13.10.1 Futura Medical Company Details
13.10.2 Futura Medical Business Overview
13.10.3 Futura Medical Erectile Dysfunction Introduction
13.10.4 Futura Medical Revenue in Erectile Dysfunction Business (2015-2020)
13.10.5 Futura Medical Recent Development
13.11 Meda Pharmaceuticals
10.11.1 Meda Pharmaceuticals Company Details
10.11.2 Meda Pharmaceuticals Business Overview
10.11.3 Meda Pharmaceuticals Erectile Dysfunction Introduction
10.11.4 Meda Pharmaceuticals Revenue in Erectile Dysfunction Business (2015-2020)
10.11.5 Meda Pharmaceuticals Recent Development
13.12 Promedon
10.12.1 Promedon Company Details
10.12.2 Promedon Business Overview
10.12.3 Promedon Erectile Dysfunction Introduction
10.12.4 Promedon Revenue in Erectile Dysfunction Business (2015-2020)
10.12.5 Promedon Recent Development
13.13 SK Chemical
10.13.1 SK Chemical Company Details
10.13.2 SK Chemical Business Overview
10.13.3 SK Chemical Erectile Dysfunction Introduction
10.13.4 SK Chemical Revenue in Erectile Dysfunction Business (2015-2020)
10.13.5 SK Chemical Recent Development
13.14 Teva Pharmaceuticals
10.14.1 Teva Pharmaceuticals Company Details
10.14.2 Teva Pharmaceuticals Business Overview
10.14.3 Teva Pharmaceuticals Erectile Dysfunction Introduction
10.14.4 Teva Pharmaceuticals Revenue in Erectile Dysfunction Business (2015-2020)
10.14.5 Teva Pharmaceuticals Recent Development
13.15 Vivus
10.15.1 Vivus Company Details
10.15.2 Vivus Business Overview
10.15.3 Vivus Erectile Dysfunction Introduction
10.15.4 Vivus Revenue in Erectile Dysfunction Business (2015-2020)
10.15.5 Vivus Recent Development
13.16 Zephyr Surgical Implants (ZSI)
10.16.1 Zephyr Surgical Implants (ZSI) Company Details
10.16.2 Zephyr Surgical Implants (ZSI) Business Overview
10.16.3 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Introduction
10.16.4 Zephyr Surgical Implants (ZSI) Revenue in Erectile Dysfunction Business (2015-2020)
10.16.5 Zephyr Surgical Implants (ZSI) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Erectile Dysfunction Key Market Segments
Table 2. Key Players Covered: Ranking by Erectile Dysfunction Revenue
Table 3. Ranking of Global Top Erectile Dysfunction Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Erectile Dysfunction Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of ED Drugs
Table 6. Key Players of ED Devices
Table 7. Global Erectile Dysfunction Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Erectile Dysfunction Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Erectile Dysfunction Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Erectile Dysfunction Market Share by Regions (2015-2020)
Table 11. Global Erectile Dysfunction Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Erectile Dysfunction Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Erectile Dysfunction Market Growth Strategy
Table 17. Main Points Interviewed from Key Erectile Dysfunction Players
Table 18. Global Erectile Dysfunction Revenue by Players (2015-2020) (Million US$)
Table 19. Global Erectile Dysfunction Market Share by Players (2015-2020)
Table 20. Global Top Erectile Dysfunction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction as of 2019)
Table 21. Global Erectile Dysfunction by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Erectile Dysfunction Product Solution and Service
Table 24. Date of Enter into Erectile Dysfunction Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 27. Global Erectile Dysfunction Market Size Share by Type (2015-2020)
Table 28. Global Erectile Dysfunction Revenue Market Share by Type (2021-2026)
Table 29. Global Erectile Dysfunction Market Size Share by Application (2015-2020)
Table 30. Global Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 31. Global Erectile Dysfunction Market Size Share by Application (2021-2026)
Table 32. North America Key Players Erectile Dysfunction Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Erectile Dysfunction Market Share (2019-2020)
Table 34. North America Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 35. North America Erectile Dysfunction Market Share by Type (2015-2020)
Table 36. North America Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 37. North America Erectile Dysfunction Market Share by Application (2015-2020)
Table 38. Europe Key Players Erectile Dysfunction Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Erectile Dysfunction Market Share (2019-2020)
Table 40. Europe Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Erectile Dysfunction Market Share by Type (2015-2020)
Table 42. Europe Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Erectile Dysfunction Market Share by Application (2015-2020)
Table 44. China Key Players Erectile Dysfunction Revenue (2019-2020) (Million US$)
Table 45. China Key Players Erectile Dysfunction Market Share (2019-2020)
Table 46. China Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 47. China Erectile Dysfunction Market Share by Type (2015-2020)
Table 48. China Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 49. China Erectile Dysfunction Market Share by Application (2015-2020)
Table 50. Japan Key Players Erectile Dysfunction Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Erectile Dysfunction Market Share (2019-2020)
Table 52. Japan Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Erectile Dysfunction Market Share by Type (2015-2020)
Table 54. Japan Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Erectile Dysfunction Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Erectile Dysfunction Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Erectile Dysfunction Market Share (2019-2020)
Table 58. Southeast Asia Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Erectile Dysfunction Market Share by Type (2015-2020)
Table 60. Southeast Asia Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Erectile Dysfunction Market Share by Application (2015-2020)
Table 62. India Key Players Erectile Dysfunction Revenue (2019-2020) (Million US$)
Table 63. India Key Players Erectile Dysfunction Market Share (2019-2020)
Table 64. India Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 65. India Erectile Dysfunction Market Share by Type (2015-2020)
Table 66. India Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 67. India Erectile Dysfunction Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Erectile Dysfunction Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Erectile Dysfunction Market Share (2019-2020)
Table 70. Central & South America Erectile Dysfunction Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Erectile Dysfunction Market Share by Type (2015-2020)
Table 72. Central & South America Erectile Dysfunction Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Erectile Dysfunction Market Share by Application (2015-2020)
Table 74. Eli Lilly Company Details
Table 75. Eli Lilly Business Overview
Table 76. Eli Lilly Product
Table 77. Eli Lilly Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 78. Eli Lilly Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Bayer Company Details
Table 85. Bayer Business Overview
Table 86. Bayer Product
Table 87. Bayer Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 88. Bayer Recent Development
Table 89. Boston Scientific Company Details
Table 90. Boston Scientific Business Overview
Table 91. Boston Scientific Product
Table 92. Boston Scientific Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 93. Boston Scientific Recent Development
Table 94. Coloplast Company Details
Table 95. Coloplast Business Overview
Table 96. Coloplast Product
Table 97. Coloplast Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 98. Coloplast Recent Development
Table 99. Apricus Biosciences Company Details
Table 100. Apricus Biosciences Business Overview
Table 101. Apricus Biosciences Product
Table 102. Apricus Biosciences Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 103. Apricus Biosciences Recent Development
Table 104. Cristalia Produtos Quimicos Farmaceuticos Company Details
Table 105. Cristalia Produtos Quimicos Farmaceuticos Business Overview
Table 106. Cristalia Produtos Quimicos Farmaceuticos Product
Table 107. Cristalia Produtos Quimicos Farmaceuticos Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 108. Cristalia Produtos Quimicos Farmaceuticos Recent Development
Table 109. Dong-A Socio Business Overview
Table 110. Dong-A Socio Product
Table 111. Dong-A Socio Company Details
Table 112. Dong-A Socio Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 113. Dong-A Socio Recent Development
Table 114. Endo Pharmaceuticals Company Details
Table 115. Endo Pharmaceuticals Business Overview
Table 116. Endo Pharmaceuticals Product
Table 117. Endo Pharmaceuticals Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 118. Endo Pharmaceuticals Recent Development
Table 119. Futura Medical Company Details
Table 120. Futura Medical Business Overview
Table 121. Futura Medical Product
Table 122. Futura Medical Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 123. Futura Medical Recent Development
Table 124. Meda Pharmaceuticals Company Details
Table 125. Meda Pharmaceuticals Business Overview
Table 126. Meda Pharmaceuticals Product
Table 127. Meda Pharmaceuticals Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 128. Meda Pharmaceuticals Recent Development
Table 129. Promedon Company Details
Table 130. Promedon Business Overview
Table 131. Promedon Product
Table 132. Promedon Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 133. Promedon Recent Development
Table 134. SK Chemical Company Details
Table 135. SK Chemical Business Overview
Table 136. SK Chemical Product
Table 137. SK Chemical Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 138. SK Chemical Recent Development
Table 139. Teva Pharmaceuticals Company Details
Table 140. Teva Pharmaceuticals Business Overview
Table 141. Teva Pharmaceuticals Product
Table 142. Teva Pharmaceuticals Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 143. Teva Pharmaceuticals Recent Development
Table 144. Vivus Company Details
Table 145. Vivus Business Overview
Table 146. Vivus Product
Table 147. Vivus Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 148. Vivus Recent Development
Table 149. Zephyr Surgical Implants (ZSI) Company Details
Table 150. Zephyr Surgical Implants (ZSI) Business Overview
Table 151. Zephyr Surgical Implants (ZSI) Product
Table 152. Zephyr Surgical Implants (ZSI) Revenue in Erectile Dysfunction Business (2015-2020) (Million US$)
Table 153. Zephyr Surgical Implants (ZSI) Recent Development
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Erectile Dysfunction Market Share by Type: 2020 VS 2026
Figure 2. ED Drugs Features
Figure 3. ED Devices Features
Figure 4. Global Erectile Dysfunction Market Share by Application: 2020 VS 2026
Figure 5. Congenital Patients Case Studies
Figure 6. Pathological Patients Case Studies
Figure 7. Erectile Dysfunction Report Years Considered
Figure 8. Global Erectile Dysfunction Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Erectile Dysfunction Market Share by Regions: 2020 VS 2026
Figure 10. Global Erectile Dysfunction Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Erectile Dysfunction Market Share by Players in 2019
Figure 13. Global Top Erectile Dysfunction Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erectile Dysfunction as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Erectile Dysfunction Revenue in 2019
Figure 15. North America Erectile Dysfunction Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Erectile Dysfunction Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Erectile Dysfunction Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Erectile Dysfunction Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Erectile Dysfunction Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Erectile Dysfunction Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Erectile Dysfunction Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
勃起不全衝撃波発生器の世界市場（～2026年） Market Analysis and Insights: Global Erectile Dysfunction Shockwave Generators Market The global Erectile Dysfunction Shockwave Generators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Erectile Dysfunction Shockwave …- 性機能障害治療薬の世界市場（～2026年） Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in th…
- 泌尿生殖器治療薬の世界市場（～2026年） A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases. The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of p…
- 先天性心疾患の世界市場（～2026年） A congenital heart disease is a problem in the structure of the heart that is present at birth. The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number …
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…